Podchaser Logo
Home
153 - ACX-362E for CDI; Cosentyx and inhibition of joint damage progression; new assays from Grifols; personalized optimization of insulin pump therapy; FDA and drug shortages for critical products; FDA guidance on attacks on food supply

153 - ACX-362E for CDI; Cosentyx and inhibition of joint damage progression; new assays from Grifols; personalized optimization of insulin pump therapy; FDA and drug shortages for critical products; FDA guidance on attacks on food supply

Released Thursday, 21st June 2018
Good episode? Give it some love!
153 - ACX-362E for CDI; Cosentyx and inhibition of joint damage progression; new assays from Grifols; personalized optimization of insulin pump therapy; FDA and drug shortages for critical products; FDA guidance on attacks on food supply

153 - ACX-362E for CDI; Cosentyx and inhibition of joint damage progression; new assays from Grifols; personalized optimization of insulin pump therapy; FDA and drug shortages for critical products; FDA guidance on attacks on food supply

153 - ACX-362E for CDI; Cosentyx and inhibition of joint damage progression; new assays from Grifols; personalized optimization of insulin pump therapy; FDA and drug shortages for critical products; FDA guidance on attacks on food supply

153 - ACX-362E for CDI; Cosentyx and inhibition of joint damage progression; new assays from Grifols; personalized optimization of insulin pump therapy; FDA and drug shortages for critical products; FDA guidance on attacks on food supply

Thursday, 21st June 2018
Good episode? Give it some love!
Rate Episode

June 21, 2018

Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com 

0:47 FDA Grants QIDP Designation to Acurx's Lead Antibiotic Product Candidate, ACX-362E for Clostridium Difficile Infection https://www.prnewswire.com/news-releases/fda-grants-qidp-designation-to-acurxs-lead-antibiotic-product-candidate-acx-362e-for-clostridium-difficile-infection-300669455.html

2:14 Novartis receives FDA approval for inclusion of new evidence that Cosentyx® inhibits progression of joint structural damage in psoriatic arthritis https://www.prnewswire.com/news-releases/novartis-receives-fda-approval-for-inclusion-of-new-evidence-that-cosentyx-inhibits-progression-of-joint-structural-damage-in-psoriatic-arthritis-300668938.html

3:22 Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays https://www.prnewswire.com/news-releases/grifols-expands-its-nat-solutions-portfolio-with-new-fda-approvals-for-two-assays-300668493.html

4:30 DreaMed Diabetes Granted FDA Authorization to Market Advisor Pro, Offering Personalized Optimization of Insulin Pump Therapy https://www.prnewswire.com/news-releases/dreamed-diabetes-granted-fda-authorization-to-market-advisor-pro-offering-personalized-optimization-of-insulin-pump-therapy-300667617.html

5:56 FDA responds to ongoing drug shortages for critical products https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm611215.htm https://www.fiercepharma.com/manufacturing/fda-says-drug-shortages-again-rise-after-5-years-improvements

8:03 New FDA guidance to help manufacturers implement protections against potential attacks on the U.S. food supply https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm611177.htm http://www.cidrap.umn.edu/news-perspective/2018/06/fda-releases-new-guidance-food-defense

Please check out my weekly podcast AI in Medicine. Podcast website is aimedicinenews.com

 

Show More
Rate

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Episode Tags

Do you host or manage this podcast?
Claim and edit this page to your liking.
,

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features